Back

Upfront combination lipid-lowering therapy in statin-naive acute coronary syndrome patients with high admission LDL-C: real-world support for the 2025 ESC dyslipidaemias guidelines

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Lipid-lowering agents: review, meta-analysis, efficacy, and clinical outcomes Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Antonio Meseguer Hernandez

General University Hospital Santa Lucia, Cartagena (Spain)

6 More presentations in this session

Presentation thumbnail
GLP-1 receptor agonist decreases VLDL-induced lipid accumulation in cardiomyocyte
Mr J. Chang (Kaohsiung, TW)
Abstract Slides
Presentation thumbnail
Real-world use of bempedoic acid for ASCVD risk reduction in a rural UK primary care practice: Analysing trends in LDL-C reduction, adherence, and ESC target attainment
Mrs M. Donaldson (Louth, GB)
Abstract Slides
Presentation thumbnail
Heterogeneous biomarker responses to CETP inhibitors: a phase 3 trials systematic review and network meta-analysis
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Class effects of subcutaneous lipoprotein(a)-lowering therapies: a systematic review and meta-analysis
Doctor M. Dogan (Greenville, US)
Abstract Slides
Presentation thumbnail
Comparative LDL-C Reduction and Cardiovascular Outcomes With PCSK9-Pathway Therapies: A Systemic Review and Network Meta-Analysis
Doctor H. Ramteke (Chimur, IN)
Abstract Slides

Access the full session

Session thumbnail
Lipid-lowering agents: review, meta-analysis, efficacy, and clinical outcomes

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Real-world use of rosuvastatin 40 mg and ezetimibe 10 mg after ACS: is this combination effective in achieving guideline-recommended LDL-C goals after discharge?
20 March 2026
thumbnail
Congress Presentation
Lipid Management in Patients with Acute Coronary Syndrome: strike early and strong!! - discussion.
18 March 2022
thumbnail
Congress Presentation
Impact of lipoprotein(a) as a residual risk on long-term cardiovascular outcomes in patients with acute coronary syndrome treated with statin
27 August 2021
thumbnail
Webinar
Post-ACS management of dyslipidaemia: tips and tricks from real world experiences
16 December 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources